OBJECTIVE: BRCA1 and BRCA2 mutation carriers are recommended to undergo risk-reducing salpingo-oophorectomy (RRSO) by age 40 and 45, respectively. However, the carriers have a different way of thinking about their life plan. We aimed to investigat...
International journal of clinical oncology 27(2) 441-447 2022年2月
BACKGROUND: This study aimed to investigate the clinical benefit of dose-dense paclitaxel plus carboplatin (TC) with bevacizumab therapy for advanced ovarian, fallopian tube, and primary peritoneal cancer patients in the neoadjuvant setting. METHO...
International Journal of Clinical Oncology 2021年12月
<title>Abstract</title><sec>
<title>Background</title>
As the population ages in developed countries, the number of Pap smears for cervical cancer screening of older women is increasing. There is concern that cervical atrophy may cause misinterp...
The role of sialic acids on MUC1 in peritoneal dissemination of ovarian cancer cells was investigated. A human ovarian carcinoma cell line, ES-2, was transfected with full-length MUC1 containing 22 or 42 tandem repeats. These transfectants were le...
Saotome K   Nomura H   Dozen A   Nanki Y   Yoshihama T   Iwasa N   Chiyoda T   Yamagami W   Kataoka F   Hirasawa A   Aoki D   
17th Biennial Meeting of the International Gynecologic Cancer Society (IGCS2018) 2018年9月16日 International Gynecologic Cancer Society
Dozen A   Nomura H   Saotome K   Nanki Y   Yoshihama T   Iwasa N   Chiyoda T   Yamagami W   Kataoka F   Hirasawa A   Aoki D   
17th Biennial Meeting of the International Gynecologic Cancer Society (IGCS2018) 2018年9月15日 International Gynecologic Cancer Society